RESUMO
Tuberculosis is a major public health problem in our country. Abdominal tuberculosis ranks third among the extrapulmonary localisations and account for 3% of the various topographic forms in Morocco. The pancreas and peripancreatic locations are much rarer than peritoneal and intestinal lesions. They present a pseudotumoral appearance that creates a diagnostic emergency. We report a case of pancreatic tuberculosis observed in the general surgery department of the 5th Military Hospital.
Assuntos
Pancreatopatias/microbiologia , Tuberculose , Adulto , Feminino , Humanos , Pancreatopatias/diagnóstico , Tuberculose/diagnósticoRESUMO
Tuberculosis is a major public health problem in Morocco. A mammary localisation is very rare. The incidence of tuberculosis remains very low, even in developing countries where it is considered endemic, but the spread of the human immunodeficiency virus has led to an increased number of cases of extrapulmonary tuberculosis, even in the most developed countries. This disease presents essentially diagnostic problems, resolved only by histological and bacteriological study. The treatment is essentially medical, based on antibacterial chemotherapy associated with surgery in some advanced cases.
Assuntos
Doenças Mamárias/microbiologia , Tuberculose , Doenças Mamárias/diagnóstico , Doenças Mamárias/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Tuberculose/diagnóstico , Tuberculose/tratamento farmacológicoRESUMO
Cerebral venous thrombosis (CVT) has been reported as an uncommon and devastating complication of ulcerative colitis (UC), with an annual incidence varying between 0,5 to 6,7%. It is suspected to be a consequence of the hypercoagulable state occurring during disease relapse. We report a case of 22-year-old female patient presenting with CVT revealing an UC. Our case raises the awareness among health professionals about the inflammatory bowel diseases (IBD) as a rare etiology of CVT, and signifies the importance of considering antithrombotic prophylaxis in all hospitalised IBD patients, especially those with active disease.